Detalles de la búsqueda
1.
Genomic-transcriptomic evolution in lung cancer and metastasis.
Nature;
616(7957): 543-552, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37046093
2.
Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA.
Nature;
616(7957): 553-562, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37055640
3.
Antibodies against endogenous retroviruses promote lung cancer immunotherapy.
Nature;
616(7957): 563-573, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37046094
4.
Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs.
Nature;
605(7911): 741-746, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35508656
5.
CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL.
Blood;
143(2): 118-123, 2024 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37647647
6.
Growing small solid nodules in lung cancer screening: safety and efficacy of a 200 mm3 minimum size threshold for multidisciplinary team referral.
Thorax;
78(2): 202-206, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36428100
7.
Faecal immunochemical test for patients with 'high-risk' bowel symptoms: a large prospective cohort study and updated literature review.
Br J Cancer;
126(5): 736-743, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34903843
8.
Telephone risk-based eligibility assessment for low-dose CT lung cancer screening.
Thorax;
77(10): 1036-1040, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35863766
9.
Detection of COPD in the SUMMIT Study lung cancer screening cohort using symptoms and spirometry.
Eur Respir J;
60(6)2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35896207
10.
The effect of clinical decision making for initiation of systemic anticancer treatments in response to the COVID-19 pandemic in England: a retrospective analysis.
Lancet Oncol;
22(1): 66-73, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33253639
11.
Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis.
Lancet Oncol;
22(5): 727-736, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33862002
12.
Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK.
Br J Cancer;
125(10): 1432-1442, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34426664
13.
Predictive classifier for intensive treatment of head and neck cancer.
Cancer;
126(24): 5263-5273, 2020 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33017867
14.
Fatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (MASCOT): an exploratory randomised Phase 2 trial utilising a modified Zelen design.
Br J Cancer;
123(2): 187-195, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32435057
15.
Nationwide randomised trial evaluating elective neck dissection for early stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort.
Br J Cancer;
121(10): 827-836, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31611612
16.
Sequential screening for lung cancer in a high-risk group: randomised controlled trial: LungSEARCH: a randomised controlled trial of Surveillance using sputum and imaging for the EARly detection of lung Cancer in a High-risk group.
Eur Respir J;
54(4)2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31537697
17.
An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor.
Gynecol Oncol;
153(3): 541-548, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31005287
18.
Effect of Single-Fraction vs Multifraction Radiotherapy on Ambulatory Status Among Patients With Spinal Canal Compression From Metastatic Cancer: The SCORAD Randomized Clinical Trial.
JAMA;
322(21): 2084-2094, 2019 12 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31794625
19.
Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial.
Lancet Oncol;
18(3): 347-356, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28209296
20.
Comparison of gefitinib, erlotinib and afatinib in non-small cell lung cancer: A meta-analysis.
Int J Cancer;
140(12): 2805-2819, 2017 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28295308